Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From ex vivo to in vivo chimeric antigen T cells manufacturing: new horizons for CAR T-cell based therapy.

Journal of translational medicine·2025
Same author

Electrochemotherapy for the treatment of primary basal cell carcinoma; A randomised control trial comparing electrochemotherapy and surgery with five year follow up.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2019
Same author

Overexpression of HER-2 via immunohistochemistry in canine urinary bladder transitional cell carcinoma - A marker of malignancy and possible therapeutic target.

Veterinary and comparative oncology·2017
Same author

The treatment of canine mast cell tumours with electrochemotherapy with or without surgical excision.

Veterinary and comparative oncology·2016
Same author

Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth.

Oncogene·2016
Same author

Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth.

Oncogene·2015

Related Experiment Video

Updated: Mar 12, 2026

Operating Procedures of the Electrochemotherapy for Treatment of Tumor in Dogs and Cats
06:32

Operating Procedures of the Electrochemotherapy for Treatment of Tumor in Dogs and Cats

Published on: October 24, 2016

27.8K

Electroporation in veterinary oncology.

J Impellizeri1, L Aurisicchio2, P Forde3

  • 1Veterinary Oncology Services, Hopewell Junction, New York 12533, USA.

Veterinary Journal (London, England : 1997)
|November 5, 2016
PubMed
Summary

New veterinary cancer therapies utilize electroporation to enhance drug delivery (electro-chemotherapy) or gene therapy (electro-gene therapy) for improved cancer treatment. These advanced techniques offer targeted local and systemic control.

Keywords:
DNA vaccinesElectro-gene therapyElectrochemotherapyElectroporationImmunotherapyVeterinary oncology

More Related Videos

High-Throughput Capable Three-Dimensional Tissue Model for Quantification of Electroporation Thresholds
08:23

High-Throughput Capable Three-Dimensional Tissue Model for Quantification of Electroporation Thresholds

Published on: August 19, 2025

656
Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures
04:01

Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures

Published on: June 23, 2023

3.1K

Related Experiment Videos

Last Updated: Mar 12, 2026

Operating Procedures of the Electrochemotherapy for Treatment of Tumor in Dogs and Cats
06:32

Operating Procedures of the Electrochemotherapy for Treatment of Tumor in Dogs and Cats

Published on: October 24, 2016

27.8K
High-Throughput Capable Three-Dimensional Tissue Model for Quantification of Electroporation Thresholds
08:23

High-Throughput Capable Three-Dimensional Tissue Model for Quantification of Electroporation Thresholds

Published on: August 19, 2025

656
Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures
04:01

Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures

Published on: June 23, 2023

3.1K

Area of Science:

  • Veterinary Medicine
  • Oncology
  • Biotechnology

Background:

  • Traditional veterinary cancer treatments include surgery, chemotherapy, and radiation.
  • Emerging technologies offer novel approaches to cancer therapy in animals.

Purpose of the Study:

  • To review electrochemotherapy and electro-gene therapy in veterinary medicine.
  • To explore future applications and directions for these novel cancer treatments.

Main Methods:

  • Review of existing literature on electrochemotherapy and electro-gene therapy in veterinary oncology.
  • Analysis of the mechanisms of electroporation for drug and gene delivery.

Main Results:

  • Electrochemotherapy uses electroporation to enhance chemotherapy drug delivery for local cancer control.
  • Electro-gene therapy employs electroporation for direct delivery of gene-based products into cancer cells for systemic control.

Conclusions:

  • Electrochemotherapy and electro-gene therapy represent significant advancements in veterinary cancer treatment.
  • These electroporation-based therapies hold promise for future applications in managing animal cancers.